---
$id: https://graph.org.ai/products/commodity/51172319
$type: Product
source: UNSPSC
code: "51172319"
title: "Cysteamine or mercaptamine"
class: "51172300"
classTitle: "Antidotes and emetics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cysteamine or mercaptamine

**UNSPSC Code**: 51172319
**Class**: [Antidotes and emetics](Antidotes and emetics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-ulcer agent with the molecular formula C2H7NS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5UX2SD1KE2, chemically known as 2-mercaptoethylamine, polymer-bound but generally known as cysteamine, which bears US NIH Compound Identifier 6058. European Medicines Agency schedules Cysteamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08770MIG. The term CYSTEAMINE is an International Non-Proprietary Name. World Health Organization schedules cysteamine in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, CYSTEAMINE remains the US FDA Preferred Term for this commodity. Cysteamine bears US NLM identifiers UMLS ID C0010648 and NCI Concept Code C61696. SMILES: C(CS)N.

